Preclinical research evidence supports that mTOR in conjunction with PI3K/Akt pathway regulates autophagy, a mechanism that could assist the body to remove malignant cells in cancer, and clear toxic proteins in AD (Heras-Sandoval et al., 2014). Here, AKT1 is linked to Alzheimer disease.